Elevated beta-lactam concentrations have been associated with neurotoxic adverse effects, including seizures and mental status changes.
Investigators used national electronic health record data to determine the proportion of American adults who have been tested for HIV.
Targeting stewardship interventions to the morning hours may have a greater impact than afternoons and nights.
Investigators sought to summarize evidence about the benefits and harms of hydroxychloroquine and chloroquine as treatments or prophylaxis of COVID-19.
Care continues to improve; however, drug-resistant pathogens and a lack of new agents to treat these infections remain a constant challenge.
George Sakoulas, MD, shares key takeaways on soft tissue infections from ID week 2023.
Teva Pharmaceuticals announces an exclusive launch of a generic version of atazanavir capsules for the treatment of HIV.
In 2017, a guideline update stripped metronidazole of its first-line therapy designation and crowned oral vancomycin as initial therapy for all C difficile infection cases.
Since its implementation in December 2016, use of a ceftolozane-tazobactam order set at Marin General Hospital has advanced antimicrobial stewardship efforts.
Final thoughts from experts on controlling COVID-19 and influenza.
Patients with a new diagnosis of HIV may benefit from rapid start of ART.
A review of the current literature and future directions.
Quick recognition is key to early initiation of treatment and long-term survival.
This In the Literature piece details a study evaluating MRSA nasal screening’s effect on antimicrobial stewardship.
Part 3 of our series looks at
Over-the-counter diagnostic tests for Chlamydia trachomatis, Neisseria gonorrhoeae, and pathogens associated with upper respiratory tract infections such as influenza and Group A Streptococcus may soon gain approval; however, making these tests immediately available to the public would not be without challenges.
A team of physicians yields surprising findings in an elderly patient in shock with seizures.
My hope is that years from now, when we look back on the coronavirus disease 2019 (COVID-19) pandemic, it will have served a few purposes.
A new study in BMC Public Health finds that neglect of skin wounds is an independent and strong risk factor for becoming a carrier of Staphylococcus aureus (S. aureus), a dangerous pathogen that can cause infections and lead to life-threatening infectious diseases.
As we await novel compounds from a relatively apathetic industry, we are resurrecting antibiotics of which we have an outdated understanding. and that carry the potential for substantial side effects: polymyxins.
Amikacin inhaled once daily for 3 days reduced risk of developing ventilator-associated pneumonia in placebo-controlled trial in critically ill.
Warnings and concerns regarding fluoroquinolones are on the rise, but the antibiotics still play a role, albeit more limited, in the treatment of various infectious diseases.
Final thoughts from experts on controlling COVID-19 and influenza.
When the CD4 count seems too good to be true.
Investigators found these populations are younger and are living at or below poverty were at lower adherence to ART.
This training will empower pharmacists practicing in LTC facilities to develop antimicrobial stewardship programs, improve patient outcomes related to infectious diseases, and facilitate compliance with CMS requirements.
A retrospective study found hepatitis C reinfection rates high are in HIV-positive men who have sex with men from four western European countries.
Lefamulin, a recently approved pleuromutilin, adds to the current antibiotic armamentarium, although its place in therapy remains to be seen.
Thomas Lodise, PharmD, PhD, provides an overview of options for treating community-acquired bacterial pneumonia and highlights the challenges of the infection.